KPY (KPYOSK) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
22 Jun, 2026Executive summary
Revenue for H1 2024 was €109.3 million, down 8.2% year-over-year, but both reported and adjusted operating results improved from the prior year.
Strategic focus remained on improving profitability in Voimatel and Enfo, while Novapolis maintained strong performance.
Voimatel divested its electricity network business, refocusing on profitable data network operations.
Enfo's IT services improved profitability, while Epical's consulting business reduced losses but remained unprofitable.
Novapolis sustained high occupancy and profitability despite market challenges.
Financial highlights
Revenue: €109.3m (vs. €119.1m), EBITDA: €5.0m (vs. €4.4m), operating result: -€0.2m (vs. -€1.5m).
Adjusted operating result: -€0.6m (vs. -€1.5m); net result: -€3.5m (vs. -€5.3m); EPS: -€0.16 (vs. -€0.24).
Net debt: €91.9m; net gearing: 92.7%; equity ratio: 33.9%.
Novapolis: revenue €14.3m, EBITDA €7.1m, operating profit €4.9m, occupancy 95.2%.
Voimatel: revenue €46.9m, operating loss -€2.4m; Enfo: revenue €49.2m, operating loss -€0.8m.
Outlook and guidance
Focus for 2024 is on maintaining Novapolis' profitability and improving results in Enfo, Epical, and Voimatel.
Novapolis expected to maintain profitability and dividend capacity, though occupancy may slightly decline.
Voimatel's results will be impacted by weak Q1 electricity network business; cost adjustments ongoing.
Enfo faces challenges in Swedish consulting; IT services outlook stable.
Medium-term goal: distribute at least 20% of net returns as dividends from 2025, rising to 60% over five years.
Latest events from KPY
- Major restructuring in 2024 led to stronger finances and a positive outlook for 2025.KPYOSK
H2 202422 Jun 2026 - Profitability rebounded in H1 2025, with improved cash flow and a positive full-year outlook.KPYOSK
H1 202522 Jun 2026 - NAV up to €246.3M, adjusted profit and cash flow improved, Sentica acquired, risks remain.KPYOSK
H2 202522 Jun 2026